Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2011, Article ID 160326, 14 pages
http://dx.doi.org/10.1155/2011/160326
Research Article

Cost-Effectiveness Evaluation of Etoricoxib versus Celecoxib and Nonselective NSAIDs in the Treatment of Ankylosing Spondylitis in Norway

1Mapi Values, Boston, MA 02114, USA
2Global Health Outcomes, Outcome Research, Merck & Co., Inc., One Merck Drive, P. O. Box 100, WS2E-85, Whitehouse Station, NJ 08889, USA

Received 7 January 2011; Accepted 20 March 2011

Academic Editor: Ruben Burgos-Vargas

Copyright © 2011 Jeroen P. Jansen and Stephanie D. Taylor. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jeroen P. Jansen and Stephanie D. Taylor, “Cost-Effectiveness Evaluation of Etoricoxib versus Celecoxib and Nonselective NSAIDs in the Treatment of Ankylosing Spondylitis in Norway,” International Journal of Rheumatology, vol. 2011, Article ID 160326, 14 pages, 2011. https://doi.org/10.1155/2011/160326.